House of Delegates discussion concludes at APhA2012

Delegates adopt policies on drug supply shortages, contemporary pharmacy practice, and controlled substances, as well as new business items.

On Monday afternoon in New Orleans, the APhA House of Delegates concluded its policy business for the 2012 Annual Meeting. The nearly 300 delegates adopted policy statements dealing with drug supply shortages and patient care, contemporary pharmacy practice, and controlled substances regulation and patient care.

With respect to drug supply shortages and patient care, delegates passed seven policy statements after little debate. The six statements on contemporary invited more debate; voting on one amendment resulted in a 50%–50% tie which was resolved by Speaker of the House Brad Tice, PharmD, PMP, FAPhA. A statement addressing “multistate pharmacist licensure agreements,” which had spurred discussion throughout the weekend, was debated at length before being accepted along with the other statements. The last set of five statements on controlled substances were adopted without amendment. The final text of the Association’s new policies will be available on shortly.

Five new business items were proposed at the meeting. Walter Chambliss, PhD, President of the APhA Academy of Pharmaceutical Research & Science (APhA–APRS), and Michael Hogue, PharmD, President of the APhA Academy of Pharmacy Practice & Management, jointly proposed four policy statements dealing with reducing counterfeit medications in response to a request from the Board of Trustees. The fifth item, proposed by Mark Boesen, PharmD, of the Arizona Caucus, dealt with the hot topic of pharmacists’ provider status under the Social Security Act.

The first three Chambliss and Hogue policies, which dealt specifically with registration of facilities, counterfeit medication and unit-of-use packaging, and drug product packaging were all adopted by the House. The New Business Review Committee recommended that delegates refer the fourth policy on medication verification to the Board of Trustees. This motion initially failed; after extensive debate, the delegates decided to divide the policy’s two statements. The more controversial statement on code scanning was referred to the Board in a close vote, while the second statement on including a description of a medication’s appearance was adopted by the House.

Delegates expressed a wide range of opinions on the final new business item on pharmacists’ inclusion in the Social Security Act. Outgoing APhA President Marialice Bennett, BSPharm, FAPhA, in one of her final acts in office, took the floor to tell pharmacists that the Association hears the concerns and wants to work towards that goal. “We are going to need your resources … to get this job done,” she said. After much debate and parliamentary discussion, the House ultimately decided to refer the proposed new business item and all pending motions to the Board for further discussion.

With the policy issues finished, the House turned to the selection and installation of new officers. After two rounds of voting, William Riffee, BSPharm, PhD, defeated Kevin Musto, BSPharm, and Andrew Young, BSPharm, for the position of Speaker-elect of the House of Delegates. Bennett swore in new trustees APhA–APRS President-elect William Fassett, PhD, MBA; APhA Academy of Student Pharmacists President-elect David Steeb; Daniel Buffington, PharmD, MBA; Jean-Venable “Kelly” Goode, PharmD, BCPS, FAPhA, FCCP; and President-elect Steve Simenson, BSPharm, FAPhA, FACA, FACVP, before handing over the reins of the Association to her successor, Jenelle Sobotka, PharmD, FAPhA.